Evidence map›Paper›PMID 41010922›Full record

Observational studyMedicina (Kaunas, Lithuania)2025

Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.

Geetha Kandasamy, Vijayakumar Arumugam, Khalid Orayj, Asma M Alshahrani, Tahani S Alanazi, Amjad Hmlan, Jithin P Venugopal

Abstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Geetha KandasamyDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
Vijayakumar ArumugamHead Pharmacy Services, Kovai Medical Center and Hospital, Coimbatore 641014, India.
Khalid OrayjDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
Asma M AlshahraniDepartment of Clinical Pharmacy, College of Pharmacy, Shaqra University, Dawadimi 11961, Saudi Arabia.
Tahani S AlanaziDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
Amjad HmlanDepartment of Clinical Pharmacy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
Jithin P VenugopalDepartment of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore 641048, India.

Funding

The authors extend their appreciation to the Deanship of Research and Graduate studies at King Khalid University for funding this work through large Research Project under grant number RGP2/44/46.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amino AcidsIschemic StrokeNeuroprotective AgentsStrokeAgedAged, 80 and overFemaleHumansMaleMiddle AgedProspective StudiesSeverity of Illness IndexTreatment OutcomeAmino AcidscerebrolysinNeuroprotective Agentsacute ischemic strokeadjuvant therapyBarthel indexcerebrolysinfunctional outcomeNIH stroke scalestandard therapy

Identifiers

PMID41010922
PMCPMC12472081

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.